Patients with vitiligo (n=11)
Populations of cells Healthy volunteers (n=10) Lesional skin Marginal skin Normally pigmented skin P P1 Р2
Epidermis (cells)
СD4+  0.0 (0.0; 0.0) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) - - -
CD8+ 0.0 (0.0; 0.0) 0.0 (0.0; 0.2)  0.0 (0.0; 0.2) 0.0 (0.0; 0.2) 0.017 0.083 0.082
CD4+/СD8+ 0.0 (0.0; 0.0) 0.0 (0.0; 0.0)  0.0 (0.0; 0.0) 0.0 (0.0; 0.0) - - -
CD83+ 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) - - -
CD1a 9.3 (8.8; 9.8) 5.0 (3.0; 7.0) 10.0 (9.2; 11.0) 10.0 (9.0; 10.8) 0.002  0.1470.322  
Derma (percent)
CD4+  6.0(5.0; 8.0) 10.0 (8.0; 14.0) 11.0 (8.0; 13.0) 10.0 (7.0; 12.0) 0.005 0.003 0.007
CD8+ 9.0(7.0; 13.0) 21.0 (17.0; 26.0) 22.0 (21.0; 28.0) 23.0 (20.0; 24.0) 0 0.001 0
CD4+/CD8+ 0.65 (0.60; 0.71) 0.47 (0.33; 0.84) 0.50 (0.33; 0.59) 0.42 (0.40; 0.55) 0.105 0.006 0.001
CD83+ 6.5 (6.0; 10.0) 22.0 (9.0; 26.0) 21.0 (8.0; 22.0) 21.0 (9.0; 26.0) 0.004 0.007 0.003
CD1a+ 6.5 (5.0; 8.0) 5.0 (3.0; 7.0) 5.0 (3.0; 6.0) 5.0 (3.0; 6.0) 0.188 0.126 0.155
Note: Р, Р1 and Р2–levels of statistical significance when comparing indicators in healthy volunteers and patients, respectively, regarding lesional skin, marginal skin, and perilesional normally pigmented skin (Mann-Whitney U-test).
Table 1: Presence of subpopulations of lymphocytes and dendritic cells in the skin of healthy volunteers and patients with vitiligo before treatment (medians and quartiles).